IP Library Granted Patent US 7,026,134
Granted Patent B2
US 7,026,134 · App. 10/323,850 · Granted Apr 11, 2006

Haptens, immunogens and antibodies to oxycodone and its metabolites

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,026,134
App. No.
10/323,850
Granted
Apr 11, 2006
Kind
B2
Abstract

Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.

Claims (17)

1. A compound of formula

wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.

2. A compound according to claim 1 , wherein R is C 1-3 alkylene.

3. A compound according to claim 1 , wherein X is COOH.

4. A compound according to claim 1 , which is N-[S-(carboxyethyl)thiopropyl]noroxycodone.

5. An immunogen comprising a compound according to claim 1 , coupled to an antigenic carrier.

6. An antibody raised against an immunogen according to claim 5 , and capable of binding with at least one epitope of oxycodone and its metabolites.

7. A conjugate comprising a compound according to claim 1 covalently bound to a detectable label.

8. A method for detecting or determining oxycodone and its metabolites in a sample, which comprises contacting the sample with a conjugate comprising a compound according to claim 1 covalently bound to a detectable label and an antibody raised against an immunogen comprising the compound of claim 1 coupled to an antigenic carrier, and being capable of binding with at least one epitope of oxycodone and its metabolites, and detecting bound conjugate.

9. A kit for determining the presence or amount of oxycodone and its metabolites in a sample, which includes a conjugate comprising a compound according to claim 1 covalently bound to a detectable label and an antibody raised against an immunogen comprising the compound of claim 1 coupled to an antigenic carrier, and being capable of binding with at least one epitope of oxycodone and its metabolites.

10. A compound according to claim 2 , wherein X is COOH.

11. An immunogen comprising a compound according to claim 2 , coupled to an antigenic carrier.

12. An immunogen comprising a compound according to claim 3 , coupled to an antigenic carrier.

13. An immunogen comprising a compound according to claim 4 , coupled to an antigenic carrier.

14. A conjugate comprising a compound according to claim 2 covalently bound to a detectable label.

15. A conjugate comprising a compound according to claim 3 covalently bound to a detectable label.

16. A conjugate comprising a compound according to claim 4 covalently bound to a detectable label.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVENYANCE PREVIOUSLY RECORDED AT REEL: 055950 FRAME: 0471. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 20, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 056210/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 055950/0471 →